BIO vs GKOS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 24, 2026

BIO

52.1
AI Score
VS
GKOS Wins

GKOS

52.3
AI Score

Investment Advisor Scores

BIO

52score
Recommendation
HOLD

GKOS

52score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric BIO GKOS Winner
Revenue 592.10M 150.57M BIO
Net Income -527.10M -19.78M GKOS
Gross Margin 52.3% 77.9% GKOS
Net Margin -89.0% -13.1% GKOS
Operating Income 34.10M -19.86M BIO
ROE -7.7% -2.9% GKOS
ROA -5.4% -2.2% GKOS
Total Assets 9.79B 893.33M BIO
Cash 507.20M 104.25M BIO
Current Ratio 3.21 5.43 GKOS
Free Cash Flow 78.10M -16.48M BIO

Relative Price Performance (Last 90 Days)

BIO 1M: +9.6% · 3M: +16.2% GKOS 1M: +21.2% · 3M: +16.0%

Current Technical Phase

BIO

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (5.7% over 20 days), RSI 67

RSI (14): 66.6 · Price: $325.48

GKOS

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (6.9% over 20 days), RSI 71

RSI (14): 71.3 · Price: $166.72

Fundamentals Snapshot

Metric BIO GKOS
Market Cap
Forward P/E 33.5 337.3
Trailing P/E 54.4
Revenue (TTM)
Revenue Growth 0.0% 0.5%
Gross Margin 0.5% 0.8%
Operating Margin 0.1% -0.1%
EPS 6.01 -3.44
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, GKOS is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.